101. Red Cells and Erythropoiesis, Excluding Iron: Poster II

Trial in progress A phase 1b open label multiple ascending dose study of OM336 a novel BCMAxCD3 T cell engager in patients with relapsed refractory autoimmune cytopenias NCT07083960

Who needs second line therapy predictors of sustained response in autoimmune hemolytic anemia

Pyruvate kinase deficiency is associated with mitochondrial retention decreased antioxidant and HIFs activity correlating with hemolysis

NLRP3 inflammasome inhibition fails to prevent red blood cell lysis in PNH

The improvement of renal function by complement inhibitors in patients with paroxysmal nocturnal hemoglobinuria

Impact of iptacopan a complement inhibitor on Chinese patients with paroxysmal nocturnal hemoglobinuria A multicenter retrospective cohort study

Efficacy and safety observation of luspatercept for refractory anemia associated with hematologic malignanciesluspatercept治疗血液系统恶性肿瘤相关难治性贫血的疗效和安全性观察luspatercept 改善与血液系统恶性肿瘤相关的难治性贫血的疗效和安全性 一项观察

Effect of baseline hemoglobin on survival in renal cell cancer patients on tyrosine kinase inhibitors

Lamin B1 mediates dynamic changes in heterochromatin and regulates erythropoiesis

ASF1B promotes erythropoiesis by regulating the establishment and dynamics of H3 3 nucleosomes

Arsenite and its primary metabolite monomethylarsonous acid impair early human red blood cell development

Mapping genomic responses to kit receptor tyrosine kinase signaling in erythroid progenitors

Impact of rilzabrutinib on gene expression of inflammatory factors in patients with warm autoimmune hemolytic anemia who participated in the Phase 2B lumina 2 study

AI based characterization of terminal erythroid differentiation as a prognostic biomarker in myelodysplastic syndromes

Real world evidence from China Clinical characteristics treatment landscape and long term outcomes in 566 autoimmune hemolytic anemia patients

Next generation sequencing panel for hereditary erythrocytosis identifies genomic variants in over half of adults with otherwise unexplained erythrocytosis

Exacerbation of anemia from hereditary spherocytosis during pregnancy Characterization of severity and use of medical interventions